The Potential Role of Scavenger Receptor B Type I (SR-BI) in SARS-CoV-2 Infection

Overview

Journal Immun Inflamm Dis

Specialties Allergy & Immunology
Infectious Diseases

Date 2023 Apr 27

PMID 37102664

Authors

Luay Alkazmi

Hayder M Al-Kuraishy

Ali I Al-Gareeb

Athanasios Alexiou

Marios Papadakis

Hebatallah M Saad

Gaber El-Saber Batiha

Affiliations

Soon will be listed here.

Abstract

Scavenger receptor type B I (SR-BI), the major receptor for high-density lipoprotein (HDL) mediates the delivery of cholesterol ester and cholesterol from HDL to the cell membrane. SR-BI is implicated as a receptor for entry of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2). SR-BI is colocalized with the angiotensin-converting enzyme 2 (ACE2) increasing the binding and affinity of SARS-CoV-2 to ACE2 with subsequent viral internalization. SR-BI regulates lymphocyte proliferation and the release of pro-inflammatory cytokines from activated macrophages and lymphocytes. SR-BI is reduced during COVID-19 due to consumption by SARS-CoV-2 infection. COVID-19-associated inflammatory changes and high angiotensin II (AngII) might be possible causes of repression of SR-BI in SARS-CoV-2 infection. In conclusion, the downregulation of SR-BI in COVID-19 could be due to direct invasion by SARS-CoV-2 or through upregulation of pro-inflammatory cytokines, inflammatory signaling pathways, and high circulating AngII. Reduction of SR-BI in COVID-19 look like ACE2 may provoke COVID-19 severity through exaggeration of the immune response. Further studies are invoked to clarify the potential role of SR-BI in the pathogenesis of COVID-19 that could be protective rather than detrimental.

Citing Articles

A six-year study in a real-world population reveals an increased incidence of dyslipidemia during COVID-19.

Trimarco V, Izzo R, Jankauskas S, Fordellone M, Signoriello G, Manzi M J Clin Invest. 2024; 134(21).

PMID: 39264723 PMC: 11527440. DOI: 10.1172/JCI183777.

The anti-inflammatory properties of vinpocetine mediates its therapeutic potential in management of atherosclerosis.

Alshehri A, Al-Kuraishy H, Al-Gareeb A, Jawad S, Khawagi W, Alexiou A J Inflamm (Lond). 2024; 21(1):19.

PMID: 38858751 PMC: 11165849. DOI: 10.1186/s12950-024-00394-x.

SARS-CoV-2 infection and dysregulation of nuclear factor erythroid-2-related factor 2 (Nrf2) pathway.

Hamad R, Al-Kuraishy H, Alexiou A, Papadakis M, Ahmed E, Saad H Cell Stress Chaperones. 2023; 28(6):657-673.

PMID: 37796433 PMC: 10746631. DOI: 10.1007/s12192-023-01379-0.

The potential role of scavenger receptor B type I (SR-BI) in SARS-CoV-2 infection.

Alkazmi L, Al-Kuraishy H, Al-Gareeb A, Alexiou A, Papadakis M, Saad H Immun Inflamm Dis. 2023; 11(4):e786.

PMID: 37102664 PMC: 10103078. DOI: 10.1002/iid3.786.

References

Hetta H, Meshaal A, Algammal A, Yahia R, Makharita R, Marraiki N . In-vitro Antimicrobial Activity of Essential Oils and Spices Powder of some Medicinal Plants Against Species Isolated from Raw and Processed Meat. Infect Drug Resist. 2020; 13:4367-4378. PMC: 7723237. DOI: 10.2147/IDR.S277295. View

Abd El-Hack M, El-Saadony M, Shehata A, Arif M, Paswan V, El-Saber Batiha G . Approaches to prevent and control Campylobacter spp. colonization in broiler chickens: a review. Environ Sci Pollut Res Int. 2020; 28(5):4989-5004. DOI: 10.1007/s11356-020-11747-3. View

Zheng Z, Ai J, Guo L, Ye X, Bondada S, Howatt D . SR-BI (Scavenger Receptor Class B Type 1) Is Critical in Maintaining Normal T-Cell Development and Enhancing Thymic Regeneration. Arterioscler Thromb Vasc Biol. 2018; 38(11):2706-2717. PMC: 6209104. DOI: 10.1161/ATVBAHA.118.311728. View

Li G, Li Y, Yamate M, Li S, Ikuta K . Lipid rafts play an important role in the early stage of severe acute respiratory syndrome-coronavirus life cycle. Microbes Infect. 2006; 9(1):96-102. PMC: 7110773. DOI: 10.1016/j.micinf.2006.10.015. View

Lacek K, Vercauteren K, Grzyb K, Naddeo M, Verhoye L, Slowikowski M . Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice. J Hepatol. 2012; 57(1):17-23. DOI: 10.1016/j.jhep.2012.02.018. View

Rivera K, Quinones V, Amigo L, Santander N, Salas-Perez F, Xavier A . Lipoprotein receptor SR-B1 deficiency enhances adipose tissue inflammation and reduces susceptibility to hepatic steatosis during diet-induced obesity in mice. Biochim Biophys Acta Mol Cell Biol Lipids. 2021; 1866(6):158909. DOI: 10.1016/j.bbalip.2021.158909. View

Ma Y, Ashraf M, Podrez E . Scavenger receptor BI modulates platelet reactivity and thrombosis in dyslipidemia. Blood. 2010; 116(11):1932-41. PMC: 3173989. DOI: 10.1182/blood-2010-02-268508. View

Marfia G, Navone S, Guarnaccia L, Campanella R, Mondoni M, Locatelli M . Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19. EMBO Mol Med. 2020; 13(1):e13424. PMC: 7744841. DOI: 10.15252/emmm.202013424. View

Wehinger A, Tancevski I, Seiler R, Frotschnig S, Frantz S, Huber J . Influence of aspirin on SR-BI expression in human carotid plaques. Atherosclerosis. 2009; 206(1):234-8. PMC: 2964595. DOI: 10.1016/j.atherosclerosis.2009.01.034. View

10.

Cao X, Tian Y, Nguyen V, Zhang Y, Gao C, Yin R . Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice. FASEB J. 2021; 35(9):e21801. PMC: 8441663. DOI: 10.1096/fj.202002742RR. View

11.

Guo L, Song Z, Li M, Wu Q, Wang D, Feng H . Scavenger Receptor BI Protects against Septic Death through Its Role in Modulating Inflammatory Response. J Biol Chem. 2009; 284(30):19826-34. PMC: 2740408. DOI: 10.1074/jbc.M109.020933. View

12.

Atmosudigdo I, Lim M, Radi B, Henrina J, Yonas E, Vania R . Dyslipidemia Increases the Risk of Severe COVID-19: A Systematic Review, Meta-analysis, and Meta-regression. Clin Med Insights Endocrinol Diabetes. 2022; 14:1179551421990675. PMC: 8842489. DOI: 10.1177/1179551421990675. View

13.

Jeandet P, Vannozzi A, Sobarzo-Sanchez E, Uddin M, Bru R, Martinez-Marquez A . Phytostilbenes as agrochemicals: biosynthesis, bioactivity, metabolic engineering and biotechnology. Nat Prod Rep. 2020; 38(7):1282-1329. DOI: 10.1039/d0np00030b. View

14.

Schulze-Luehrmann J, Ghosh S . Antigen-receptor signaling to nuclear factor kappa B. Immunity. 2006; 25(5):701-15. DOI: 10.1016/j.immuni.2006.10.010. View

15.

Liu X, Xiong S, Yi G . ABCA1, ABCG1, and SR-BI: Transit of HDL-associated sphingosine-1-phosphate. Clin Chim Acta. 2011; 413(3-4):384-90. DOI: 10.1016/j.cca.2011.11.002. View

16.

Hariyanto T, Kurniawan A . Dyslipidemia is associated with severe coronavirus disease 2019 (COVID-19) infection. Diabetes Metab Syndr. 2020; 14(5):1463-1465. PMC: 7395301. DOI: 10.1016/j.dsx.2020.07.054. View

17.

Alomair B, Al-Kuraishy H, Al-Gareeb A, Al-Hamash S, De Waard M, Sabatier J . Montelukast and Acute Coronary Syndrome: The Endowed Drug. Pharmaceuticals (Basel). 2022; 15(9). PMC: 9500901. DOI: 10.3390/ph15091147. View

18.

Wood P, Mulay V, Darabi M, Chan K, Heeren J, Pol A . Ras/mitogen-activated protein kinase (MAPK) signaling modulates protein stability and cell surface expression of scavenger receptor SR-BI. J Biol Chem. 2011; 286(26):23077-92. PMC: 3123075. DOI: 10.1074/jbc.M111.236398. View

19.

Amin S, Aktar S, Rahman M, Chowdhury M . NLRP3 inflammasome activation in COVID-19: an interlink between risk factors and disease severity. Microbes Infect. 2021; 24(1):104913. PMC: 8613976. DOI: 10.1016/j.micinf.2021.104913. View

20.

Abouelezz K, Khanapara D, El-Saber Batiha G, A Ahmed E, Hetta H . Cytotoxic Chemotherapy as an Alternative for Systemic Treatment of Advanced Hepatocellular Carcinoma in Developing Countries. Cancer Manag Res. 2020; 12:12239-12248. PMC: 7707432. DOI: 10.2147/CMAR.S280631. View